Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.
Clinical trial NCT02141230 · WITHDRAWN
Trial details
- NCT number
- NCT02141230
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.